What is leukemia?

Written by He Li Fang
Hematology
Updated on September 03, 2024
00:00
00:00

Leukemia is a malignant tumor of the hematopoietic system that originates from hematopoietic stem/progenitor cells. It involves leukemia cells that have proliferative and survival advantages, proliferating and accumulating uncontrollably in the body, gradually replacing normal hematopoiesis to form pathological hematopoiesis. Furthermore, it invades other organs and systems, leading to symptoms such as anemia, bleeding, and infections, which eventually cause death. The incidence of leukemia is 4.8/100000-7.1/100000 in males and 3.2/100000-4.6/100000 in females, with significant variations in incidence, mortality rates, and distribution among different types of leukemia and various regions and ethnic groups. Early on, it was recognized that leukemia is not an inflammation, and the views that leukemia is caused by a lack of certain substances have been proven incorrect. Currently, it is understood that the causative factors of leukemia are related to infections, radiation, chemical agents, lifestyle, and genetics.

Other Voices

doctor image
home-news-image
Written by He Li Fang
Hematology
1min 20sec home-news-image

Is leukemia treatment free?

Leukemia is a type of malignant tumor originating from hematopoietic stem cells and progenitor cells in the myeloid hematopoietic system. Leukemia cells differentiate and organize at the early stages of different myeloid developments, exhibiting the morphological and immunophenotypic characteristics of myeloid development. The incidence of acute myeloid leukemia in the population is 2-4/100,000, with the median age of onset being sixty-four to seventy years, making it a disease of the elderly. The incidence increases with age, accounting for 70% of acute leukemias, and representing 55%-70% of infant, 17%-20% of childhood, and 80%-90% of adult acute leukemias. Regarding the medical insurance situation in China, some leukemia conditions are eligible for major illness assistance. All leukemia treatments can be reimbursed at a certain ratio under the national health insurance, although there is no free treatment for leukemia at present, unless one participates in relevant clinical trials, which could offer some compensation, and certain treatment drugs are provided free of charge.

doctor image
home-news-image
Written by He Li Fang
Hematology
1min 51sec home-news-image

Chronic granulocytic leukemia symptoms

The clinical symptoms of chronic myeloid leukemia can be divided into two phases: 1. During the chronic phase, the earliest subjective symptoms include fatigue, dizziness, and abdominal discomfort. Other symptoms may also appear such as general malaise, decreased endurance, and nausea. Some patients may exhibit signs of increased basal metabolism, such as sweating, weight loss, palpitations, and nervousness. As the disease progresses, patients may experience enlargement of the liver and spleen. An enlarged spleen can cause abdominal bloating, discomfort in the upper left abdomen, and a feeling of fullness after eating. In a few cases, bleeding may occur in the early stages. In female patients, excessive menstruation is common, and while bone pain and joint pain are less common at initial diagnosis, they can also occur. 2. During the accelerated phase, patients often exhibit unexplained low-grade fever, fatigue, lack of appetite, night sweats, and increased weight loss. These symptoms are accompanied by rapid enlargement of the spleen causing discomfort and fullness, sudden swelling of lymph nodes, clear sternal tenderness, and osteolytic changes in bones leading to bone pain. Anemia also progressively worsens. Once patients enter the blast crisis phase, they may show extramedullary infiltration symptoms such as skin nodules, testicular infiltration, abnormal penile erections, and the appearance of green tumors in the eye sockets, among other serious complications.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
47sec home-news-image

Is leukemia cancer?

Leukemia is a cancer of the blood system. Based on the maturity of the tumor cells, leukemia can be divided into acute leukemia and chronic leukemia. Acute leukemia is further divided into acute myeloid leukemia and acute lymphoblastic leukemia, while chronic leukemia is divided into chronic granulocytic leukemia and chronic lymphocytic leukemia. As the name suggests, acute leukemia has a rapid onset, a shorter survival period, and treatment is more challenging. Chronic leukemia, on the other hand, has a slower onset, a relatively longer survival period, and the treatment results are comparatively better.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
52sec home-news-image

The Difference Between Acute Leukemia and Chronic Leukemia

The difference between acute and chronic leukemia lies in the maturity stage of the leukemia cells. Acute leukemia is characterized by more immature leukemia cells, while chronic leukemia cells tend to be more mature. Acute leukemia is further divided into acute myeloid leukemia and acute lymphoblastic leukemia. Among them, acute myeloid leukemia is subdivided into eight types, from M0 to M7. Chronic leukemia is divided into two main categories: chronic lymphocytic leukemia and chronic myeloid leukemia. As the name suggests, acute leukemia has a rapid onset and a shorter survival period, whereas chronic leukemia develops more slowly and has a longer life expectancy.

doctor image
home-news-image
Written by He Li Fang
Hematology
54sec home-news-image

chronic granulocytic leukemia platelets

Patients with chronic granulocytic leukemia have variations in blood platelets as seen in routine blood tests, which differ according to different stages of the disease. In the chronic phase, especially early on, platelet counts are mostly elevated or normal, with increases potentially exceeding 1000x10^9 per liter. The shape of the platelets is normal, but their function is often abnormal, with thrombus formation being rare. A minority of patients may experience a decrease in platelet count. As the disease progresses, routine blood tests can reveal significant decreases or increases in platelet counts along with the appearance of megakaryocytes. Additionally, some patients may also exhibit bone marrow fibrosis, characterized by an increase in reticular fibers or collagen fibers.